NCT00289172View on ClinicalTrials.gov

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

PHASE3CompletedINTERVENTIONAL

Enrollment

360

Participants

Timeline

Start Date

February 10, 2006

Study Completion Date

September 8, 2006

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Live attenuated human rotavirus vaccine

Trial Locations (4)

632002

GSK Investigational Site, Vellore

700010

GSK Investigational Site, Kolkata

Oin-160 012

GSK Investigational Site, Chandigarth

411 011

GSK Investigational Site, Pune

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY